Improving drug discovery through parallelism.

J Supercomput

Supercomputing - Algorithms Research Group (SAL), Agrifood Campus of International Excellence, University of Almería, Carretera Sacramento s/n, La Cañada de San Urbano, 04120 Almería, Spain.

Published: January 2023

Compound identification in ligand-based virtual screening is limited by two key issues: the quality and the time needed to obtain predictions. In this sense, we designed OptiPharm, an algorithm that obtained excellent results in improving the sequential methods in the literature. In this work, we go a step further and propose its parallelization. Specifically, we propose a two-layer parallelization. Firstly, an automation of the molecule distribution process between the available nodes in a cluster, and secondly, a parallelization of the internal methods (initialization, reproduction, selection and optimization). This new software, called pOptiPharm, aims to improve the quality of predictions and reduce experimentation time. As the results show, the performance of the proposed methods is good. It can find better solutions than the sequential OptiPharm, all while reducing its computation time almost proportionally to the number of processing units considered.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842220PMC
http://dx.doi.org/10.1007/s11227-022-05014-0DOI Listing

Publication Analysis

Top Keywords

improving drug
4
drug discovery
4
discovery parallelism
4
parallelism compound
4
compound identification
4
identification ligand-based
4
ligand-based virtual
4
virtual screening
4
screening limited
4
limited key
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!